Features, Strategies and Promises of Medical Imaging
Hospital revitalisation initiatives serve as the major driver for improved medical imaging equipment within the public healthcare sector. Growth of the market within the private sector is increasing in proportion to the rapidly emerging technology within the medical imaging space as private healthcare end users try to remain competitive. This briefing will investigate the dynamics of the South African medical imaging market, with specific reference to five key device segments, including, general X-rays, fluoroscopy, mammography, computed tomography (CT) scanners and magnetic resonance imaging (MRI) scanners.
RecordedApr 11 201324 mins
Your place is confirmed, we'll send you email reminders
The US medical imaging industry is transforming to cope with the challenges of the present and the demands of the future. The current care provision landscape is highly fragmented, and a coherent strategy is required to enhance interoperability among stakeholders across the imaging ecosystem. This is essential to bring about standardization of the care protocols, development of new industry best practices and improvement of workflow productivity—essential prerequisites toward improving the efficiency of care provision, improving patient outcomes and lowering costs. Stakeholders across the industry must also come together to eliminate redundancies and duplications, and streamline the imaging process, to improve the patient experience. Market participants need to work more collaboratively with care providers to address unmet needs and develop technologies and solutions that help care providers address regulatory and reimbursement compliances without having to invest in additional manpower and resources.
Reenita Das, Partner, Kamaljit Behera, Industry Analyst, Neil Jordan, Microsoft, Kay Eron, Intel, Keith Bigelow,GE Healthcare
2018 will be a tipping point for mainstream adoption of popular digital health technology solutions such as artificial intelligence, mHealth/wearables, telehealth, Big Data analytics, and robotics. The transition of technologies from ideation to actionable applications will drive new opportunities across the globe.
From data monetization unleashing the power of patient data to digital transformation of patient monitoring, there will be growing awareness of current inefficiencies and new opportunities identified to improve the efficiency of healthcare delivery.
Rhenu Bhuller, Partner & Sanjeev Kumar, Industry Manager (Frost & Sullivan), Dr. Allen Lai, SVP of ACT Genomics Singapore
The industry is being disrupted by integration of the multi-disciplinary capabilities in biology, chemistry and computational power that companies can leverage to develop new solutions to diagnose, treat and manage chronic disease conditions, such as cancer, cardiovascular disease and diabetes. There is immense pressure on companies to build competencies in product development, manufacturing and distribution of new technology platforms such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market—a paradigm shift that will transform clinical practice and treatment outcomes.
We invite you to join Frost & Sullivan’s Transformational Healthcare team and industry experts to discuss blockchain technology with the most potential applications across the healthcare industry, including data interoperability, cybersecurity, insurance fraud management, and drug supply chain provenance. Learn how to differentiate the hype from reality and hear key strategic considerations for future success.
Daniel Ruppar, Global Program Director - Digital Health
Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space evolves we have experienced a multitude of stepwise successes and stellar failures, yet funding continues to flood the sector. Major moves continue to come into the industry from the broader vendor environment, underlining the importance of health in everyone’s lives and progressively in strategic interests of the C-Suite across the ecosystem. Join Frost & Sullivan in this webinar update showcasing different facets of the market, and learn why there’s something for everyone in digital health.
Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
Next-generation sequencing (NGS) has emerged as a key technology to deliver the next level of healthcare solutions. While the $1,000 genome was achieved in 2015, Frost & Sullivan predicts the $100 genome to be possible by 2024. The significant dip in cost of extracting genetic data has led to the creation of massive genomic data volumes that are expected to be some of the largest data sets globally by 2025, exceeding data generated by YouTube and Twitter.
Frost & Sullivan, Gabe Rjipma,Microsoft, Dr. Timothy Low, Farrer Park Hospital, David Vu, GE Healthcare Asia-Pacific
Hospital information technology (Hospital IT) spending in Asia-Pacific (APAC) will grow at a compound annual growth rate of 9.7% between 2016 and 2021 to reach an estimated end-stage market size of more than $15 billion. Key growth opportunities in the region include solutions for Healthcare Data Continuity, Patient Engagement & Experience, Healthcare Cloud, Big Data & Analytics, and Healthcare Cybersecurity. However, the identification of these growth opportunities is only the first step toward succeeding as an ICT vendor in this market. The real demystification lies in understanding very specific target customer needs and then building a value proposition and business model that addresses those needs.
Transformational Health Team, Harry Glorikian, Board Advisor and Eunice Teo, Director, Business Development, QuantuMDx
The global clinical diagnostics industry is undergoing a transformation propelled by laboratory consolidation and automation, an enormous move toward data-driven healthcare, large investments in unifying technologies, and renewed business models driven by products and value-added services. There is immense pressure on companies to radically improve new product innovation, manufacturing, and distribution of technologies such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market.
Digital Health Team: Daniel Ruppar, Nancy Fabozzi and Victor Camlek
Over the past decade, the adoption of digital solutions has increased significantly throughout the healthcare industry. This exceptionally strong growth trajectory is expected to continue into the foreseeable future as U.S. healthcare organizations transform to meet the demand for more efficient, clinically integrated and decentralized care systems that serve empowered, technologically-savvy consumers who strongly value convenience and personalization.
Visionary Healthcare Team: Venkat Rajan and Siddharth Shah
The healthcare industry is undergoing rapid transformation. By 2025, the healthcare ecosystem is expected to look drastically different from today. In 2025, global trends of aging populations, rising chronic disease prevalence and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. In response, new business models are expected to emerge to address the needs of the future. In order to make the most gains, stakeholders must successfully leverage this transformation.
Christi Bird, Senior Industry Analyst, Szilard Voros, Founder and CEO Global Genomics Group
This briefing will answer the following key questions:
· How are technology trends, such as new sequencers on the high end (Illumina HiSeq X Ten) and low end (Illumina MiniSeq, Oxford Nanopore MinION), impacting NGS services providers?
· How will the market change in accordance with the declining cost of sequencing, which hit the $1,000 genome mark?
· When will the $100 genome be realized, and how will that achievement occur?
· What are “answer-based services,” and why should NGS service providers be concerned about an impending paradigm shift in the way research questions are answered?
· How should NGS service providers be positioning now in order to take advantage of the various changes expected in the marketplace over the next 10 years, as well as the growth opportunities available from these changes?
Divyaa Ravishankar, Paul Pickering, CEO, Ubiquitome, Herbert Torfs, VP Business Development and Strategy, GenePOC
This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the point-of-care testing industry. We will also be joined by Paul Pickering, president and CEO, Ubiquitome, and Herbert Torfs, VP Business Development and Strategy, GenePOC, who will discuss their experience with market trends, regulatory road blocks, and unaddressed needs in the US, Europe, and developing and underdeveloped nations.
Frost & Sullivan Transformational Health Team, Chris Chen, CEO, WuXi Biologics, Steve Lam, Senior Vice President, Patheon
Questions this briefing will address:
· What are the key challenges the CMOs are likely to face in the near- and long-term future? How can CMOs strategize to overcome these hurdles?
· What growth opportunities exist in the pharmaceutical contract manufacturing industry?
· In what ways is the pharmaceutical contract manufacturing industry likely to change to meet industry trends and dynamics?
· Who are the game-changing companies, and what are the disruptive technologies and business models?
· How should CMOs strategically position their assets with pharma companies?
Transformational Health Team: Nitin Naik, Divyaa Ravishankar, Christi Bird, and Unmesh Lal
The global pharmaceutical industry is witnessing an unprecedented era. Several new demand spaces such as innovative therapeutics (immuno-oncology), clinical diagnostics (liquid biopsy), and research tools (next-generation sequencing) have emerged, driving companies to sharpen their long-term positions. Fundamental behavioral shifts in these spaces are redefining the market. Companies are adopting a “beyond-the-pill” approach and increasing investments in innovations related to drug discovery, clinical trials, supply-chain solutions, and patient engagement. This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the life sciences industry.
Why You Must Attend:
• For hospitals to succeed, it is imperative to create a strategy that allows optimal alignment of care provision between providers. There is no “one-size-fits-all approach” to remain competitive.
•This briefing assesses different strategies adopted by hospitals, which range from smart collaborations with different ambulatory care providers to efficiently manage care transition, adoption of data integration solutions to better create standards of care protocols, and launch of in-house insurance plans to increase patient volumes.
• An understanding of these strategies is critical for hospitals to create bespoke integrated care delivery solutions that can be used to address local requirements.
• This briefing also highlights the financial impact of adopting such integrated models of care delivery.
Demand for telehealth is on the rise in APAC as healthcare industry stakeholders across the region seek to address challenges of an ageing population and rising healthcare costs. However, market sustainability heavily depends on the establishment of successful business models that provide holistic health and wellness solutions by creating an ecosystem of products and services. In this briefing we will discuss the APAC Telehealth market opportunity with in-depth analysis of technologies, regulations, industry partnerships and business models that will help shape the future of care delivery in the region.
Rhenu Bhuller, Venkat Rajan,Kamaljit Behera - Frost & Sullivan
Industry convergence and technological innovations are giving rise to a new breed of wearable technologies that are capable of meeting the unique needs and requirements of clinical care settings. Unlike more prevalent general health and fitness devices, these wearables can function with higher levels of accuracy and reliability allowing them to be used by medical professionals to make assessments and recommendations for patients.
In this interactive briefing, Frost & Sullivan’s Transformational Health team will explore the future applications and opportunities for these innovations, and key strategy considerations for developers.
Dorman Followwill, Richard Weissenberg, Venkat Rajan
The healthcare industry is fundamentally influenced by the deployment of technology. More than any other industry, healthcare can benefit from the adoption, and Africa is uniquely positioned to gain from the advances. The audience will receive the following advantages by attending the presentation:
• Frost & Sullivan will share top predictions for the healthcare industry in Africa for 2016
• Learn about key trends in the African healthcare industry
• Uncover areas of opportunity in healthcare
• Participate in an interactive Q&A session
Transformational Health Team: Daniel Ruppar, Nancy Fabozzi, Victor Camlek, and Koustav Chatterjee
Connected healthcare continues to expand as innovations in technology and services flourish. Consequently, the adoption of digital health solutions has increased significantly throughout the industry.
While the U.S. healthcare system evolves and embraces lower costs and improving quality of care and access, opportunities are emerging in connected healthcare. The industry is driven by health IT development, growth of connected and savvy users, as well as cloud based- software as a service (SaaS) delivery models.
Join Frost & Sullivan’s Connected Health team, as they host a panel discussion on the 2016 connected healthcare predictions and current insights on key areas within the market. The panel will be followed by a live Q&A session. This is the first of the Connected Health team’s new quarterly webinar series.
Attend this webinar to discover:
• Key market predictions including merger and acquisitions (M&A), partnerships, as well as areas of growth and controversy in 2016
• New data regarding consumers; how they view their health and interests in digital health tools
• Latest perspectives on telehealth and remote patient monitoring
• The progression of the ambulatory electronic health records space and what this means for providers
Rhenu Bhuller - Partner & SVP, Natasha Gulati - Industry Manager, Siddharth Shah - Industry Analyst
Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments, which shoulder the largest burden of paying for healthcare services will take decisive steps towards innovating their healthcare systems so that they can be prepared for challenges of the future. This will call for a complete transformation of the way healthcare is delivered in APAC with all key stakeholders – pharma companies, device manufacturers and healthcare services providers – racing to reinvent their business models. In this briefing we present major healthcare industry trends for APAC and their impact on businesses in 2016.
Our Healthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.